Drug Profile
Sipoglitazar
Alternative Names: TAK 654Latest Information Update: 12 Sep 2006
Price :
$50
*
At a glance
- Originator Takeda
- Class Insulin sensitisers
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 12 Sep 2006 Discontinued - Phase-II for Diabetes mellitus in USA (unspecified route)
- 07 Sep 2006 Discontinued - Phase-II for Diabetes mellitus in Europe (unspecified route)
- 07 Sep 2006 Discontinued - Phase-II for Diabetes mellitus in Japan (unspecified route)